Wellnex Life Limited - Change of Chief Financial Officer

Wellnex Life

01/09/2026 07:00

RNS Number : 7195S
  
Wellnex Life Limited
  
01 September 2026
  
 


 ASX/AIM Announcement        
                                                                                                                        1 September 2026
Change of Chief Financial Officer
Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") advises that Ms Vivienne Zhang will step down from her role as Chief Financial Officer ("CFO"), with Mr Joe Rinarelli appointed as the Company's new Chief Financial Officer.
Mr Rinarelli is an experienced Chartered Accountant with more than 15 years of accounting and finance experience.
Mr Rinarelli will commence in the role on 1 September 2026 on a part-time basis.
To support an orderly and seamless handover, Ms Zhang will remain engaged by the Company as a consultant for a transitional period, working closely with Mr Rinarelli and the management team to facilitate the transfer of responsibilities and corporate knowledge.
Commenting on the transition, Wellnex Life Interim Executive Chair Eric Jiang, said:
"On behalf of the Board and everyone at Wellnex, I would like to thank Vivienne for her dedication, commitment and strong work ethic during her tenure as Chief Financial Officer. Vivienne has played an important role in the Company's recent transformation, particularly in supporting the Company's corporate strategy and the execution of the recent divestment of Pain Away. We are pleased that Vivienne will continue to support the Company as a consultant during the transition period, ensuring an orderly handover to Joe. The Board and management team wish Vivienne every success in her future endeavours.
We are also pleased to welcome Joe to Wellnex. His extensive accounting and finance experience, including his experience with ASX-listed companies, will be valuable as Wellnex enters its next phase. His appointment on a part-time basis also reflects the Company's ongoing focus on maintaining an efficient corporate cost base as we execute our go-forward strategy."
This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).
--- END ---
For further information, please contact:
Wellnex Life Limited (ASX/AIM:WNX)                            
Eric Jiang                                                                             
Interim Executive Chairman                                                            
E: eric.j@wellnexlife.com.au    
 
UK Investors
Strand Hanson (Financial & Nominated Advisor)
James Harris / Richard Johnson                                      Tel: +44 (0) 20 7409 3494
 
Orana Corporate LLP (Joint Broker)                                 swykeham@oranacorp.com
Sebastian Wykeham    
 
S.P. Angel Corporate Finance LLP (Joint Broker)        Tel: +44 (0)20 3470 0470
David Hignell / Vadim Alexandre
 
To learn more, please visit: https://wellnexlife.com.au/




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAFLFFFTLILVIR